Biotech and Biometric

ATLANTA, Ga. -- M2SYS, an award-winning biometric technology research and development firm announced today that LunchByte Systems, Inc., home of the NUTRIKIDS brand of foodservice management solutions, has integrated M2SYS' unique Bio-SnapON(TM) solution into their lunchline POS system; instantly increasing the security and efficiency of their application.

PASADENA, Calif. -- Osmetech plc (LSE, AIM; OMH) today announced that it has granted a non-exclusive research license to Waltham, Massachusetts, US-based Minerva Biotechnologies Corporation ("Minerva") for use of Osmetech's self-assembling monolayer (SAM) technology in conjunction with Minerva's proprietary nanoparticle technology. Osmetech is a fast developing, international molecular diagnostics business.

FRESNO, Calif. -- Cypress Systems, Inc, a Fresno CA based biotechnology company, announced that it has hired Mark Whitacre, Ph.D. Dr. Whitacre joined the executive management team effective January 1, 2007 as COO & President, Technology and Business Development, following the opening of a new office in Pensacola, Florida in December, 2006.

SAN MARINO, Calif. -- Epeius Biotechnologies announced the publication of a historic landmark in medical oncology and a definitive benchmark in the emerging field of cancer gene therapy. The first clinical report of its kind, Le Morte du Tumour - published in the June issue of the International Journal of Oncology, documents the histologic features of tumor destruction observed in chemo-resistant cancers.

SAN MARINO, Calif. -- Epeius Biotechnologies Corporation announced today the expansion of ongoing clinical trials using Rexin-G(TM) in the United States to include breast cancer and all types of sarcomas that have failed standard chemotherapy. Following on the heels of their landmark clinical trials in the United States and abroad, the US FDA granted Orphan Drug Status for Rexin-G.

SAN MARINO, Calif. -- Epeius Biotechnologies Corporation today announced that Dr. Frederick L. Hall, President and CEO of Epeius Biotechnologies, has accepted an invitation to speak during the 9th annual C21 BioVentures Conference. On May 23 at 11:15 am, Dr. Hall will present the scientific principles, clinical validation, and global development status of the company's innovative tumor-targeting technology embodied in its lead product, Rexin-G, the first targeted genetic medicine developed to treat metastatic cancer.

ATLANTA, Ga. -- Frost & Sullivan presented M2SYS Technology with its 2007 North American Biometrics Technology Innovation of the Year Award at the 2007 North American Excellence in Industrial Technologies Awards Banquet. Frost and Sullivan chose M2SYS as the recipient of this prestigious award after a year-long evaluation of products from every biometrics company in the industry.

ATLANTA, Ga. -- M2SYS Technology announced today the completion of an ongoing case study with point of sale solutions partner, LCR Limited. In early 2006, LCR integrated M2SYS' flagship fingerprint software, Bio-Plugin(TM), into their QuickDine(TM) school lunchroom management software to provide an alternative to magnetic swipe-cards that were previously used to identify students purchasing lunch.

ATLANTA, Ga. -- M2SYS Technology announced today that it was selected late in 2006 by a leading Nigerian IT products provider to deliver fingerprint scanners and software for the secure national voting project. After the original local vendor selected for the project faced delays in meeting its timeline for the fulfillment of a portion of needed IT units, Nigerian government officials sought out the help of another company, who turned to M2SYS for assistance.

ATLANTA, Ga. -- M2SYS Technology announced today that it has formed a strategic partnership with Schoolhouse Software, a leading provider of K-12 lunch line management systems. This partnership will benefit school customers by enabling Schoolhouse to integrate M2SYS' market revolutionizing fingerprint software technology, Bio-Plugin(TM), within their Touch-n-Serv(TM) K-12 school lunch line POS solution.

ATLANTA, Ga. -- M2SYS Technology announced today it has formed a relationship with Kodak's Dental Systems Group to integrate M2SYS' patent-pending fingerprint software into the KODAK ORTHOTRAC Practice Management Software. As a result, Kodak's customers will be able to secure sensitive patient information and comply with HIPAA requirements, while improving productivity and user experience by eliminating the time, hassle, and headache associated with password management.

SAN MARINO, Calif. and MANILA, Philippines -- Epeius Biotechnologies today announced the publication of clinical data from studies conducted at the University of the Philippines, Asian Hospital and Medical Center, Makati Medical Center, Manila, Philippines and Lutheran Medical Center, New York, USA, revealing the safety and single agent efficacy of Rexin-G(TM) for the treatment of a broad spectrum of chemotherapy-resistant cancers.

ATLANTA, Ga. -- M2SYS Technology, a biometric technology research and development company, announced today it has formed a partnership with PCS Revenue Control Systems, a leading provider of foodservice management technology. This partnership will benefit school districts by enabling PCS to integrate and distribute M2SYS' cutting edge fingerprint software technology, Bio-Plugin(TM), within their FASTRAK(TM) school meal software.

JESSUP, Md. -- ACell, Inc., the owner of highly valued extracellular matrix (ECM) patents, along with co-defendants Dr. Stephen Badylak and Dr. Alan Spievack, today won another legal victory against Cook Biotech, Inc. (Cook) and Purdue Research Foundation (Purdue) when the Court of Appeals for the Federal Circuit denied Cook's and Purdue's Petition for Rehearing and Rehearing En Banc. In the Petition Cook and Purdue had requested both the original Federal Circuit three judge panel and the entire Federal Circuit Court to reconsider a detailed 29 page written opinion issued on August 18, 2006.

MECHELEN, Belgium -- Responding to the need to make timely evaluations and decisions when treating treatment experienced HIV patients, Virco Labs (www.vircolab.com), a leader in drug resistance testing recently introduced an improved virco(R)TYPE HIV-1 test that rapidly determines the complex phenotypic resistance profiles for darunavir, tipranavir and other antiretroviral (ARV) drugs.

SAN MARINO, Calif. -- Epeius Biotechnologies Corporation today announced that Dr. Frederick Hall, President and CEO of Epeius Biotechnologies, has accepted an invitation to speak at the upcoming Global Pharmaceutical Research & Development Summit held on Oct. 24 at 4:10 p.m. (PT) in Anaheim, Calif. Dr. Hall will present the current status of global development and the broad pharmaceutical indications for the company's innovative targeting technology platform.

JESSUP, Md. -- ACell, Inc., the owner of highly valued extracellular matrix (ECM) patents, today won a resounding legal victory against Cook Biotech, Inc. (Cook) and Purdue Research Foundation (Purdue). The victory frees ACell to broadly promote the development, licensing and commercialization of its remarkable tissue graft bio-technology.

ATLANTA, Ga. -- M2SYS Technology, a leading biometric technology research and development firm, today announced a new version release of Bio-Plugin(TM), a fully developed, server-based, enterprise fingerprint recognition system that can be rapidly deployed, in many cases with no additional development whatsoever.